Free Trial

Versor Investments LP Takes $558,000 Position in Xylem Inc. $XYL

Xylem logo with Business Services background

Key Points

  • Versor Investments LP has acquired 4,674 shares of Xylem Inc., valued at approximately $558,000, during the first quarter.
  • Xylem reported $1.26 earnings per share (EPS) for the last quarter, exceeding analysts' expectations and showing a 6.1% revenue increase year-over-year.
  • The company also announced a quarterly dividend of $0.40 per share, representing an annualized yield of 1.1% for shareholders of record.
  • Looking to export and analyze Xylem data? Unlock 5 Weeks of MarketBeat All Access for Just $5. Claim Your Limited-Time Discount.

Versor Investments LP acquired a new stake in Xylem Inc. (NYSE:XYL - Free Report) in the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund acquired 4,674 shares of the industrial products company's stock, valued at approximately $558,000.

A number of other large investors have also recently made changes to their positions in the company. Corient IA LLC purchased a new stake in shares of Xylem during the first quarter worth approximately $597,000. Northwest & Ethical Investments L.P. raised its position in shares of Xylem by 3.2% during the 1st quarter. Northwest & Ethical Investments L.P. now owns 234,430 shares of the industrial products company's stock worth $28,005,000 after acquiring an additional 7,308 shares in the last quarter. Raymond James Financial Inc. raised its position in shares of Xylem by 7.9% during the 1st quarter. Raymond James Financial Inc. now owns 376,253 shares of the industrial products company's stock worth $44,947,000 after acquiring an additional 27,657 shares in the last quarter. Cresset Asset Management LLC raised its position in shares of Xylem by 14.4% during the 1st quarter. Cresset Asset Management LLC now owns 4,731 shares of the industrial products company's stock worth $565,000 after acquiring an additional 596 shares in the last quarter. Finally, Boston Family Office LLC raised its stake in Xylem by 10.6% during the 1st quarter. Boston Family Office LLC now owns 86,887 shares of the industrial products company's stock worth $10,380,000 after acquiring an additional 8,308 shares in the last quarter. 87.96% of the stock is currently owned by hedge funds and other institutional investors.

Xylem Stock Performance

Shares of NYSE XYL traded up $3.4010 during midday trading on Friday, reaching $143.6210. 1,186,118 shares of the company were exchanged, compared to its average volume of 1,212,842. The company has a current ratio of 1.90, a quick ratio of 1.43 and a debt-to-equity ratio of 0.17. Xylem Inc. has a 1 year low of $100.47 and a 1 year high of $145.33. The stock has a fifty day simple moving average of $134.27 and a 200 day simple moving average of $126.45. The stock has a market cap of $34.96 billion, a P/E ratio of 37.30, a PEG ratio of 2.43 and a beta of 1.11.

Xylem (NYSE:XYL - Get Free Report) last released its quarterly earnings results on Thursday, July 31st. The industrial products company reported $1.26 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.15 by $0.11. Xylem had a return on equity of 10.33% and a net margin of 10.74%.The firm had revenue of $2.30 billion for the quarter, compared to analyst estimates of $2.20 billion. During the same quarter last year, the company posted $1.09 earnings per share. The business's revenue was up 6.1% on a year-over-year basis. Xylem has set its FY 2025 guidance at 4.700-4.850 EPS. On average, research analysts forecast that Xylem Inc. will post 4.65 earnings per share for the current fiscal year.

Xylem Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Thursday, September 25th. Stockholders of record on Thursday, August 28th will be paid a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a dividend yield of 1.1%. The ex-dividend date is Thursday, August 28th. Xylem's payout ratio is 41.56%.

Analysts Set New Price Targets

Several research firms have issued reports on XYL. Royal Bank Of Canada upped their price objective on shares of Xylem from $143.00 to $147.00 and gave the company an "outperform" rating in a research note on Wednesday, April 30th. Citigroup reissued a "buy" rating and issued a $152.00 target price (up from $137.00) on shares of Xylem in a research report on Monday, July 14th. Robert W. Baird decreased their target price on Xylem from $149.00 to $146.00 and set an "outperform" rating for the company in a research report on Wednesday, April 30th. Raymond James Financial raised Xylem to a "hold" rating in a research report on Thursday, May 15th. Finally, Stifel Nicolaus upped their target price on Xylem from $162.00 to $175.00 and gave the company a "buy" rating in a research report on Friday, August 1st. Six investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to MarketBeat, Xylem presently has a consensus rating of "Moderate Buy" and a consensus target price of $151.57.

Check Out Our Latest Research Report on XYL

Xylem Company Profile

(Free Report)

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.

Featured Articles

Institutional Ownership by Quarter for Xylem (NYSE:XYL)

Should You Invest $1,000 in Xylem Right Now?

Before you consider Xylem, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Xylem wasn't on the list.

While Xylem currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Next Tech Boom: AI Robots Are Coming Sooner Than You Think!
Tech Stocks Stumble: Will Nvidia’s Report Spark a Rebound?
Follow the Money: 5 Stocks Institutions Are Buying NOW

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines